Woodline Partners LP Charles River Laboratories International, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $3.42 Million - $4.59 Million	16,780 New	16,780 $4.55 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $4.37 Million - $5.58 Million	-12,426 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $8.74 Million - $10.7 Million	-23,450 Reduced 65.36%	12,426 $5.13 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $1.22 Million - $1.54 Million	4,140 Added 13.05%	35,876 $13.3 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $1.38 Million - $1.66 Million	5,533 Added 21.12%	31,736 $9.2 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $5.82 Million - $6.62 Million	26,203 New	26,203 $6.55 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.